Skip to main content

twitter
facebook
youtube
instagram

Donate to EGFR Resisters to Continue Vital Research

Hit enter to search or ESC to close

HOME
WHO WE ARE
PROJECTS & EDUCATION
NEWS
SOCIAL MEDIA
ALLIANCES & RESOURCES
DONATE

TargetedOnc_CMYK_gradienttrans

Latest Newsletter

Leave a Reply Cancel Reply

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Share Tweet Share Pin

We are a group of lung cancer patients with EGFR mutations who have developed resistance to at least one targeted treatment drug, or who face probable resistance in the future. Caregivers are also welcome. We are here to share treatment experiences, information about clinical trials, breaking news about research developments, and other information with each other.

Medical Disclaimer

QUICK LINKS

Home
Donate
News
Join

WHO WE ARE

Leadership
Our Mission
Expert Partnerships
Young Investigators
Membership

PROJECTS

About EGFR
Project Priority
Annual Research Summit
Research Awards
Education

ALLIANCES & RESOURCES

Monthly Newsletters
Lung Cancer Advocacy
Biomarker Groups
Contact Us

© 2023 EGFR Lung Cancer Resisters. Built by Reinhardt Designs.

twitter
facebook
youtube
instagram
email

HOME
WHO WE ARE
PROJECTS & EDUCATION
NEWS
SOCIAL MEDIA
ALLIANCES & RESOURCES
DONATE

twitter
facebook
youtube
instagram